The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine ...
New drugs may have important yet underappreciated clinical consequences in patients requiring blood transfusion. Interference with routine methods for compatibility testing for blood transfusion puts ...